HomeInsightsPB

Gland Pharma Ltd PB Ratio

Gland Pharma Ltd PB Ratio

stocks purchased

₹ 1.4 Cr

Volume transacted

stocks purchased

7.6 K

stocks traded

Last Updated time: 18 Sep 9.00 AM

Image

Gland Pharma Ltd

NSE: GLAND

PB

3.5

Last updated: 18 Sep 24

Key Highlights

  • The P/B Ratio of Gland Pharma Ltd is 3.5 as of 18 Sep 24.
  • The P/B Ratio of Gland Pharma Ltd changed from 7.5 on March 2022 to 3.5 on March 2024 . This represents a CAGR of -22.43% over 3 years. .

Historical P/B Ratio of Gland Pharma Ltd

No data available

Company Fundamentals for Gland Pharma Ltd

Market Cap

30,353 Cr

EPS

43.8

P/E Ratio (TTM) *

42.0

P/B Ratio (TTM) *

3.5

Day’s High *

1862.0

Day’s Low

1826.05

DTE *

0.0

ROE *

8.9

52 Week High

2220.95

52 Week Low

1477.0

ROCE *

12.7

Share price Over Time

1M

1Y

3Y

5Y

Monitoring Gland Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Share Price

Date
leftPriceleft
18 Sep 20241842.35
17 Sep 20241847.05
16 Sep 20241865.5
13 Sep 20241877.6
12 Sep 20241889.35
11 Sep 20241889.75
10 Sep 20241927.1
09 Sep 20241902.6
06 Sep 20241904.85
05 Sep 20241890.95

SWOT Analysis Of Gland Pharma Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Gland Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Gland Pharma Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/B Ratio

Company NamePBMarket Cap (INR Cr.)
Gland Pharma Ltd330,353
Sun Pharmaceuticals Industries Ltd984,39,714
Divis Laboratories Ltd5071,45,166
Cipla Ltd3461,33,402
Torrent Pharmaceuticals Ltd2011,13,724
Dr Reddys Laboratories Ltd14581,09,604

Key Valuation Metric of Gland Pharma Ltd

The price-to-book (P/B) ratio compares a company's market capitalization to its book value by dividing its stock price per share by its book value per share.


How to calculate Price-to-Book (P/B) Ratio?

The Price-to-Book Ratio is used to determine the relationship between the total value of a company's outstanding shares and the net value of its assets. Before calculating the P/B ratio, investors need to overlook the market capitalization of a company.


Market capitalization = market value of a stock X no. of outstanding shares


Now, you need to know the net value of an organization's assets.

Book Value of Assets = Total Assets - Total Liabilities of a company


After knowing the value of the above ratios, here is the formula for the P/B Ratio:

P/B Ratio = Market Capitalization/ Book Value of Assets


or you can also use this formula

P/B ratio = Market Price Per Share/ Book Value of Asset Per Share

Historical Market Cap of Gland Pharma Ltd

No data available

* All values are in crore

Historical Revenue of Gland Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Gland Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Gland Pharma Ltd

No data available

* All values are in crore

Dividend per Share (DPS) Over Time

No data available

Gland Pharma Ltd News Hub

News

Gland Pharma Ltd gains for third straight session

Gland Pharma Ltd gained for a third straight session today. The stock is quoting at Rs 193...

Read more

09 Sep 202413:05

News

Gland Pharma slides after Q1 PAT slumps 26% YoY to Rs 144 cr

Revenue from operations jumped 15.97% YoY to Rs 1,401.70 crore in Q1 FY25. Profit before t...

Read more

07 Aug 202411:27

News

US FDA issues 3 Form 483 observations to Gland Pharma's Pashamylaram facility

The said inspection was conducted between 25 July 2024 and 02 August 2024. The said inspec...

Read more

05 Aug 202412:19

News

USFDA conducts surprise inspection of Gland Pharma's Dundigal facility

Gland Pharma announced that the United States Food and Drug Administration (US FDA) has co...

Read more

25 Jul 202413:49

News

Gland Pharma receives USFDA tentative approval for Latanoprostene Bunod Ophthalmic Solution

Gland Pharma has received tentative approval from the United States Food and Drug Administ...

Read more

24 Jul 202410:09

News

Gland Pharma schedules board meeting

Gland Pharma will hold a meeting of the Board of Directors of the Company on 6 August 2024...

Read more

20 Jul 202412:06

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Oct 2022

PPT

July 2022

TranscriptPPT

Sep 2021

PPT

July 2021

TranscriptPPT

Feb 2021

Transcript

FAQs for PB Ratio of Gland Pharma Ltd

What is the PB ratio of Gland Pharma Ltd?

The current PB ratio of Gland Pharma Ltd is 3.48. The Price-to-Book value (P/B) ratio compares a company's current share price to its book value per share. It helps assess whether a stock is overvalued or undervalued relative to its net asset value.

What is the ideal PB ratio to buy Gland Pharma Ltd stocks?

An ideal PB ratio varies by industry; however, a PB ratio below 1.0 may indicate a good buying opportunity for Gland Pharma Ltd. Some investors and financial analysts may also consider any value under 3.0 as a good PB ratio.

How is the PB Ratio of Gland Pharma Ltd calculated?

The PB ratio of Gland Pharma Ltd is calculated by dividing the current share price by the book value per share. The book value per share is determined by dividing the company’s total net assets (assets minus liabilities) by the number of outstanding shares. This ratio helps evaluate how the market values the company's assets.

What does a high PB Ratio mean for Gland Pharma Ltd?

A high PB ratio suggests that Gland Pharma Ltd’s stock may be overvalued relative to its book value or that investors expect high growth.

What does a low PB Ratio indicate for Gland Pharma Ltd?

A low PB ratio of Gland Pharma Ltd may indicate that the stock is undervalued or it is facing financial difficulties.

Can Gland Pharma Ltd PB Ratio change over time?

Yes, the PB ratio of Gland Pharma Ltd can change over time due to fluctuations in the company’s stock price and changes in its book value.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*